LIJ first in NY area to offer revolutionary prostate treatment.NEW HYDE PARK New Hyde Park, village (1990 pop. 9,728), Nassau co., SE N.Y., on Long Island; inc. 1927. It is a residential community with some manufacturing and truck farms. Nearby is the uninc. town of North New Hyde Park (1990 pop. 14,359). , N.Y.--(BUSINESS WIRE)--Sept. 5, 1996--Long Island Jewish Medical Center (LIJ) is the first hospital in the New York tri-state region offering new, non-surgical treatment for the symptoms of benign prostatic enlargement. The condition, Benign Prostatic Hyperplasia benign prostatic hyperplasia n. Abbr. BPH A nonmalignant enlargement of the prostate gland commonly occurring in men after the age of 50, and sometimes leading to compression of the urethra and obstruction of the flow of urine. or BPH BPH abbr. benign prostatic hyperplasia BPH Benign prostatic hypertrophy, a very common noncancerous cause of prostatic enlargement in older men. , is estimated to affect half of all men over age 60. Until recently, it could be alleviated only by major surgery or medication that frequently have negative side effects. In May 1996, the U.S. Food and Drug Administration (FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. ) approved the Prostatron manufactured by EDAP EDAP Eating Disorders Awareness and Prevention EDAP Extended Data Availability and Protection (fault tolerant disk technology) EDAP Emergency Department Approved for Pediatrics EDAP Energy Descent Action Plan Technomed Inc. for treatment of non-cancerous prostatic hyperplasia. It is the only microwave device for BPH to undergo and be approved through the FDA's rigorous Pre-Market Approval (PMA PMA (papillary-marginal-attached), n a system of epidemiologic scoring of periodontal disease devised by Schour and Massler in which the symbols denote the areas involved in gingival inflammation. PMA Progressive muscular atrophy ) process. With the Prostatron, microwaves are used for rapid heating to safely eliminate excess prostate cells thereby relieving the symptoms of enlarged prostate such as the need to urinate frequently. The hour-long procedure requires no anesthesia and is done on an outpatient basis. A cooling system circulates water to protect adjoining tissue while fiberoptic thermosensors monitor temperatures. The single-session procedure is known as TransUrethral Microwave Thermotherapy or TUMT TUMT Transurethral microwave therapy, see there . Arthur Smith M.D., chairman of Urology at LIJ states, "Men suffering from prostate enlargement have everything to gain and nothing to lose with this innovative approach to overcoming their discomfort. It is painless, far less costly than surgery and allows patients to resume normal activities almost immediately. In the few instances where the Prostatron is not the solution, surgery still remains an option." During clinical trials, 75 percent of the men treated with the Prostatron experienced improvement in symptoms. Studies showed that the therapy did not result in incontinence or impact negatively on sexual function - potential difficulties after surgery. The technique has been used in Europe and Asia since 1991, and 35,000 patients have been treated with the Prostatron worldwide. EDAP Technomed is a pioneer in the development of minimally invasive, cost-effective medical therapies. Headquartered in Paris, France, the company's principal US offices are in Cambridge, MA and Chicago, IL. For more information, call 800-933-TUMT or the LIJ Urology Department at 718-470-4555. CONTACT: EDAP Technomed Inc. Christine Meehan, 617/441-9212 |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion